1-15 of 15
Tao Liu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract B029: Ultra-sensitive molecular residual disease detection through whole genome sequencing with single-read error correction

Xinxing Li, Tao Liu, Antonella Bacchiocchi, Mengxing Li, Wen Cheng, Tobias Wittkop, Fernando Mendez, Yingyu Wang, Paul Tang, George Yeung, Qianqian Yao, Marcus Bosenberg, Mario Sznol, Qin Yan, Malek Faham, Li Weng, Ruth Halaban, Hai Jin, Zhiqian Hu
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (21_Supplement): B029.
https://doi.org/10.1158/1557-3265.LIQBIOP24-B029
Published: 13 November 2024
View articletitled, Abstract B029: Ultra-sensitive molecular residual disease detection through whole genome sequencing with single-read error correction
Journal Articles

Genomic Profiling of Radiation-Induced Sarcomas Reveals the Immunologic Characteristics and Its Response to Immune Checkpoint Blockade

Dong-Chun Hong, Jing Yang, Cong Sun, Yuan-Tao Liu, Lu-Jun Shen, Bu-Shu Xu, Yi Que, Xiaojun Xia, Xing Zhang
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (15): 2869–2884.
https://doi.org/10.1158/1078-0432.CCR-22-3567
Published: 01 August 2023
View articletitled, Genomic Profiling of Radiation-Induced Sarcomas Reveals the Immunologic Characteristics and Its Response to Immune Checkpoint Blockade
Open the PDF for Genomic Profiling of Radiation-Induced Sarcomas Reveals the Immunologic Characteristics and Its Response to Immune Checkpoint Blockade in another window
Includes: Supplementary data
Journal Articles

Correction: Pik3ip1 Is a Negative Immune Regulator that Inhibits Antitumor T-Cell Immunity

Yichen Chen, Jun Wang, Xi Wang, Xinye Li, Jingjing Song, Juan Fang, Xiangqi Liu, Tao Liu, Dikan Wang, Qunxing Li, Shuqiong Wen, Da Ma, Juan Xia, Liqun Luo, Song Guo Zheng, Jun Cui, Gucheng Zeng, Lieping Chen, Bin Cheng, Zhi Wang
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (10): 2197.
https://doi.org/10.1158/1078-0432.CCR-22-1109
Published: 13 May 2022
View articletitled, Correction: Pik3ip1 Is a Negative Immune Regulator that Inhibits Antitumor T-Cell Immunity
Open the PDF for Correction: Pik3ip1 Is a Negative Immune Regulator that Inhibits Antitumor T-Cell Immunity in another window
Journal Articles

Targeted Therapy of TERT-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination Therapy

Jingwei Chen, Christopher Nelson, Matthew Wong, Andrew E. Tee, Pei Y. Liu, Ting La, Jamie I. Fletcher, Alvin Kamili, Chelsea Mayoh, Christoph Bartenhagen, Toby N. Trahair, Ning Xu, Nisitha Jayatilleke, Marie Wong, Hui Peng, Bernard Atmadibrata, Belamy B. Cheung, Qing Lan, Tracy M. Bryan, Pieter Mestdagh, Jo Vandesompele, Valerie Combaret, Valentina Boeva, Jenny Y. Wang, Isabelle Janoueix-Lerosey, Mark J. Cowley, Karen L. MacKenzie, Alla Dolnikov, Jinyan Li, Patsie Polly, Glenn M. Marshall, Roger R. Reddel, Murray D. Norris, Michelle Haber, Matthias Fischer, Xu D. Zhang, Hilda A. Pickett, Tao Liu
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (5): 1438–1451.
https://doi.org/10.1158/1078-0432.CCR-20-3044
Published: 01 March 2021
View articletitled, Targeted Therapy of TERT-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination Therapy
Open the PDF for Targeted Therapy of TERT-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination Therapy in another window
Includes: Supplementary data
Journal Articles

Pik3ip1 Is a Negative Immune Regulator that Inhibits Antitumor T-Cell Immunity

Yichen Chen, Jun Wang, Xi Wang, Xinye Li, Jingjing Song, Juan Fang, Xiangqi Liu, Tao Liu, Dikan Wang, Qunxing Li, Shuqiong Wen, Da Ma, Juan Xia, Liqun Luo, Song Guo Zheng, Jun Cui, Gucheng Zeng, Lieping Chen, Bin Cheng, Zhi Wang
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2019) 25 (20): 6180–6194.
https://doi.org/10.1158/1078-0432.CCR-18-4134
Published: 01 October 2019
View articletitled, Pik3ip1 Is a Negative Immune Regulator that Inhibits Antitumor T-Cell Immunity
Open the PDF for Pik3ip1 Is a Negative Immune Regulator that Inhibits Antitumor T-Cell Immunity in another window
Includes: Supplementary data
Journal Articles

PIK3CA Mutations Contribute to Acquired Cetuximab Resistance in Patients with Metastatic Colorectal Cancer

Jian-Ming Xu, Yan Wang, You-Liang Wang, Yan Wang, Tao Liu, Ming Ni, Man-Sheng Li, Li Lin, Fei-Jiao Ge, Chun Gong, Jun-Yan Gu, Ru Jia, He-Fei Wang, Yu-Ling Chen, Rong-Rui Liu, Chuan-Hua Zhao, Zhao-Li Tan, Yang Jin, Yun-Ping Zhu, Shuji Ogino, Zhi-Rong Qian
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2017) 23 (16): 4602–4616.
https://doi.org/10.1158/1078-0432.CCR-16-2738
Published: 14 August 2017
View articletitled, PIK3CA Mutations Contribute to Acquired Cetuximab Resistance in Patients with Metastatic Colorectal Cancer
Open the PDF for PIK3CA Mutations Contribute to Acquired Cetuximab Resistance in Patients with Metastatic Colorectal Cancer in another window
Includes: Supplementary data
Journal Articles

PD-L1 Is a Therapeutic Target of the Bromodomain Inhibitor JQ1 and, Combined with HLA Class I, a Promising Prognostic Biomarker in Neuroblastoma

Ombretta Melaiu, Marco Mina, Marco Chierici, Renata Boldrini, Giuseppe Jurman, Paolo Romania, Valerio D'Alicandro, Maria C. Benedetti, Aurora Castellano, Tao Liu, Cesare Furlanello, Franco Locatelli, Doriana Fruci
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (15): 4462–4472.
https://doi.org/10.1158/1078-0432.CCR-16-2601
Published: 01 August 2017
View articletitled, PD-L1 Is a Therapeutic Target of the Bromodomain Inhibitor JQ1 and, Combined with HLA Class I, a Promising Prognostic Biomarker in Neuroblastoma
Open the PDF for PD-L1 Is a Therapeutic Target of the Bromodomain Inhibitor JQ1 and, Combined with HLA Class I, a Promising Prognostic Biomarker in Neuroblastoma in another window
Includes: Supplementary data
Journal Articles

Abstract A31: Proteomic characterization of stromal contribution to tumor using patient-derived xenografts

Jason E. McDermott, Tao Liu, Vladislav Petyuk, Richard Smith, Karin Rodland
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (16_Supplement): A31.
https://doi.org/10.1158/1557-3265.PDX16-A31
Published: 15 August 2016
View articletitled, Abstract A31: Proteomic characterization of stromal contribution to tumor using patient-derived xenografts
Journal Articles

The Bromodomain Inhibitor JQ1 and the Histone Deacetylase Inhibitor Panobinostat Synergistically Reduce N-Myc Expression and Induce Anticancer Effects

Jeyran Shahbazi, Pei Y. Liu, Bernard Atmadibrata, James E. Bradner, Glenn M. Marshall, Richard B. Lock, Tao Liu
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (10): 2534–2544.
https://doi.org/10.1158/1078-0432.CCR-15-1666
Published: 12 May 2016
View articletitled, The Bromodomain Inhibitor JQ1 and the Histone Deacetylase Inhibitor Panobinostat Synergistically Reduce N-Myc Expression and Induce Anticancer Effects
Open the PDF for The Bromodomain Inhibitor JQ1 and the Histone Deacetylase Inhibitor Panobinostat Synergistically Reduce N-Myc Expression and Induce Anticancer Effects in another window
Includes: Supplementary data
Journal Articles

Adrenergic Stimulation of DUSP1 Impairs Chemotherapy Response in Ovarian Cancer

Yu Kang, Archana S. Nagaraja, Guillermo N. Armaiz-Pena, Piotr L. Dorniak, Wei Hu, Rajesha Rupaimoole, Tao Liu, Kshipra M. Gharpure, Rebecca A. Previs, Jean M. Hansen, Cristian Rodriguez-Aguayo, Cristina Ivan, Prahlad Ram, Vasudha Sehgal, Gabriel Lopez-Berestein, Susan K. Lutgendorf, Steven W. Cole, Anil K. Sood
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (7): 1713–1724.
https://doi.org/10.1158/1078-0432.CCR-15-1275
Published: 31 March 2016
View articletitled, Adrenergic Stimulation of DUSP1 Impairs Chemotherapy Response in Ovarian Cancer
Open the PDF for Adrenergic Stimulation of DUSP1 Impairs Chemotherapy Response in Ovarian Cancer in another window
Includes: Supplementary data
Journal Articles

XPO1/CRM1 Inhibition Causes Antitumor Effects by Mitochondrial Accumulation of eIF5A

Takahito Miyake, Sunila Pradeep, Sherry Y. Wu, Rajesha Rupaimoole, Behrouz Zand, Yunfei Wen, Kshipra M. Gharpure, Archana S. Nagaraja, Wei Hu, Min Soon Cho, Heather J. Dalton, Rebecca A. Previs, Morgan L. Taylor, Takeshi Hisamatsu, Yu Kang, Tao Liu, Sharon Shacham, Dilara McCauley, David H. Hawke, John E. Wiktorowicz, Robert L. Coleman, Anil K. Sood
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (14): 3286–3297.
https://doi.org/10.1158/1078-0432.CCR-14-1953
Published: 14 July 2015
View articletitled, XPO1/CRM1 Inhibition Causes Antitumor Effects by Mitochondrial Accumulation of eIF5A
Open the PDF for XPO1/CRM1 Inhibition Causes Antitumor Effects by Mitochondrial Accumulation of eIF5A in another window
Includes: Supplementary data
Journal Articles

Cross-talk between EphA2 and BRaf/CRaf Is a Key Determinant of Response to Dasatinib

Jie Huang, Wei Hu, Justin Bottsford-Miller, Tao Liu, Hee Dong Han, Behrouz Zand, Sunila Pradeep, Ju-Won Roh, Duangmani Thanapprapasr, Heather J. Dalton, Chad V. Pecot, Rajesh Rupaimoole, Chunhua Lu, Bryan Fellman, Diana Urbauer, Yu Kang, Nicholas B. Jennings, Li Huang, Michael T. Deavers, Russell Broaddus, Robert L. Coleman, Anil K. Sood
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (7): 1846–1855.
https://doi.org/10.1158/1078-0432.CCR-13-2141
Published: 31 March 2014
View articletitled, Cross-talk between EphA2 and BRaf/CRaf Is a Key Determinant of Response to Dasatinib
Open the PDF for Cross-talk between EphA2 and BRaf/CRaf Is a Key Determinant of Response to Dasatinib in another window
Includes: Supplementary data
Journal Articles

Targeting Src and Tubulin in Mucinous Ovarian Carcinoma

Tao Liu, Wei Hu, Heather J. Dalton, Hyun Jin Choi, Jie Huang, Yu Kang, Sunila Pradeep, Takahito Miyake, Jian H. Song, Yunfei Wen, Chunhua Lu, Chad V. Pecot, Justin Bottsford-Miller, Behrouz Zand, Nicholas B. Jennings, Cristina Ivan, Gary E. Gallick, Keith A. Baggerly, David G. Hangauer, Robert L. Coleman, Michael Frumovitz, Anil K. Sood
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (23): 6532–6543.
https://doi.org/10.1158/1078-0432.CCR-13-1305
Published: 01 December 2013
View articletitled, Targeting Src and Tubulin in Mucinous Ovarian Carcinoma
Open the PDF for Targeting Src and Tubulin in Mucinous Ovarian Carcinoma in another window
Includes: Supplementary data
Journal Articles

Levels of Expression of CYR61 and CTGF Are Prognostic for Tumor Progression and Survival of Individuals with Gliomas

Dong Xie, Dong Yin, He-Jing Wang, Gen-Tao Liu, Robert Elashoff, Keith Black, H. Phillip Koeffler
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (6): 2072–2081.
https://doi.org/10.1158/1078-0432.CCR-0659-03
Published: 24 March 2004
View articletitled, Levels of Expression of CYR61 and CTGF Are Prognostic for Tumor Progression and Survival of Individuals with Gliomas
Open the PDF for Levels of Expression of CYR61 and CTGF Are Prognostic for Tumor Progression and Survival of Individuals with Gliomas in another window
Journal Articles

MIC-1 Serum Level and Genotype: Associations with Progress and Prognosis of Colorectal Carcinoma

David A. Brown, Robyn L. Ward, Philip Buckhaults, Tao Liu, Katharine E. Romans, Nicholas J. Hawkins, Asne R. Bauskin, Kenneth W. Kinzler, Bert Vogelstein, Samuel N. Breit
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (7): 2642–2650.
Published: 01 July 2003
View articletitled, MIC-1 Serum Level and Genotype: Associations with Progress and Prognosis of Colorectal Carcinoma
Open the PDF for MIC-1 Serum Level and Genotype: Associations with Progress and Prognosis of Colorectal Carcinoma in another window